Veracyte (VCYT) Payables (2016 - 2025)
Historic Payables for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $5.5 million.
- Veracyte's Payables fell 4303.0% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 4303.0%. This contributed to the annual value of $8.6 million for FY2024, which is 3329.21% down from last year.
- Per Veracyte's latest filing, its Payables stood at $5.5 million for Q3 2025, which was down 4303.0% from $11.4 million recorded in Q2 2025.
- In the past 5 years, Veracyte's Payables registered a high of $15.7 million during Q1 2025, and its lowest value of $5.5 million during Q3 2025.
- Moreover, its 5-year median value for Payables was $11.4 million (2025), whereas its average is $11.2 million.
- Its Payables has fluctuated over the past 5 years, first surged by 47976.19% in 2021, then crashed by 4303.0% in 2025.
- Over the past 5 years, Veracyte's Payables (Quarter) stood at $12.4 million in 2021, then decreased by 3.63% to $11.9 million in 2022, then increased by 8.66% to $12.9 million in 2023, then tumbled by 33.29% to $8.6 million in 2024, then plummeted by 36.19% to $5.5 million in 2025.
- Its last three reported values are $5.5 million in Q3 2025, $11.4 million for Q2 2025, and $15.7 million during Q1 2025.